GARDNER, Mass., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2016.
First quarter highlights include:
- Revenues of $850 thousand, nearly the same as $856 thousand in the first quarter of fiscal 2016;
- 19.7% gross margin, a relative improvement of 28% compared to gross margin of 15.4% in the first quarter of fiscal 2016;
- 23% year-over-year decrease in quarterly net loss on similar level quarterly revenues; and
- On-going progress toward conversion of multiple engineering projects to production orders.
Commenting on the first quarter results, Joseph Forkey, Company CEO said, “While our revenues in the first quarter of fiscal 2017 were nearly the same as a year ago, gross margin was significantly higher, reflecting, in part, improvements in manufacturing efficiencies that we have achieved over the past year. As our overall revenues increase, we expect these efficiencies to continue to help us achieve higher margins. These improved gross margins as well as lower operating expenses, contributed to reduced losses at the same level of revenues compared to the same quarter one year ago.
Dr. Forkey continued, “We are pleased with our improved performance at this level of sales while we continue our progress toward increased production revenues resulting from conversion of our engineering service contracts. We are also seeing continued interest in our development capabilities as we evaluate new requests from existing and new potential customers for our engineering services on various medical device visualization systems that can benefit from our unique technologies and know-how.”
The following table summarizes the first quarter results for the periods ended September 30, 2016 and 2015 (unaudited):
| Three Months Ended September 30, | ||||||||||
| 2016 | 2015 | |||||||||
| Revenues | $ | 849,548 | $ | 858,427 | ||||||
| Gross Profit | 167,051 | 132,338 | ||||||||
| Operating Expenses | 460,459 | 514,228 | ||||||||
| Net Loss | (293,408 | ) | (381,890 | ) | ||||||
| Loss Per Share: | ||||||||||
| Basic | $ | (0.04 | ) | $ | (0.06 | ) | ||||
| Diluted | $ | (0.06 | ) | $ | (0.06 | ) | ||||
| Weighted Average Common Shares Outstanding: | ||||||||||
| Basic and Diluted | 7,539,582 | 6,389,806 | ||||||||
Quarterly Conference Call Details
The Company has scheduled a conference call to discuss the fiscal first quarter 2017 financial results for Monday, November 14, 2016 at 5:00 PM Eastern. To participate in the conference call, please dial 1-866-652-5200 toll free from the U.S., or 1-412-317-6060, and ask to be connected to the Precision Optics conference call.
An audio replay of the conference call will be available approximately one hour after the conclusion of the call and will be made available until November 28, 2016. The audio replay can be accessed by dialing 1-412-317-0088 locally or 1-877-344-7529, toll free then enter conference ID number 10093345.
About Precision Optics Corporation
Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, MicroprecisionTM micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for a broad range of customers including some of the largest global medical device companies. The Company’s innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company’s website is www.poci.com. Investors can find Real-Time Quotes and market information for the Company on www.otcmarkets.com/stock/PEYE/quote.
About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law.
Following are the Company’s consolidated balance sheets as of September 30, 2016 and June 30, 2016, and statements of operations for the three months ended September 30, 2016 and 2015 and statements of cash flows for the three months ended September 30, 2016 and 2015 (unaudited):
| PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES | ||||||||
| CONSOLIDATED BALANCE SHEETS | ||||||||
| (UNAUDITED) | ||||||||
| September 30, 2016 | June 30, 2016 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS | ||||||||
| Cash and Cash Equivalents | $ | 202,406 | $ | 50,059 | ||||
| Accounts Receivable, net | 566,053 | 750,380 | ||||||
| Inventories, net | 992,472 | 1,133,451 | ||||||
| Prepaid Expenses | 81,832 | 88,129 | ||||||
| Total Current Assets | 1,842,763 | 2,022,019 | ||||||
| PROPERTY AND EQUIPMENT | ||||||||
| Machinery and Equipment | 2,482,971 | 2,479,471 | ||||||
| Leasehold Improvements | 553,596 | 553,596 | ||||||
| Furniture and Fixtures | 148,303 | 148,303 | ||||||
| Vehicles | 19,674 | 19,674 | ||||||
| 3,204,544 | 3,201,044 | |||||||
| Less: Accumulated Depreciation and Amortization | (3,130,470 | ) | (3,122,849 | ) | ||||
| Net Fixed Assets | 74,074 | 78,195 | ||||||
| Patents, net | 23,214 | 22,874 | ||||||
| TOTAL ASSETS | $ | 1,940,051 | $ | 2,123,088 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| CURRENT LIABILITIES | ||||||||
| Current Portion of Capital Lease Obligation | $ | 7,987 | $ | 7,857 | ||||
| Accounts Payable | 1,211,646 | 1,151,561 | ||||||
| Customer Advances | 11,025 | - | ||||||
| Accrued Employee Compensation | 184,307 | 238,381 | ||||||
| Accrued Professional Services | 91,350 | 65,550 | ||||||
| Accrued Warranty Expense | 25,000 | 25,000 | ||||||
| Other Accrued Liabilities | 24,162 | 15,612 | ||||||
| Total Current Liabilities | 1,555,477 | 1,503,961 | ||||||
| Capital lease obligation, net of current portion | 29,909 | 31,955 | ||||||
| STOCKHOLDERS’ EQUITY | ||||||||
| Common stock, $0.01 par value - Authorized - 50,000,000 shares; Issued and Outstanding – 7,539,582 shares at September 30, 2016 and June 30, 2016 | 75,396 | 75,396 | ||||||
| Additional Paid-in Capital | 44,236,952 | 44,176,051 | ||||||
| Accumulated deficit | (43,957,683 | ) | (43,664,275 | ) | ||||
| Total Stockholders’ Equity | 354,665 | 587,172 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 1,940,051 | $ | 2,123,088 | ||||
| PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES | ||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
| FOR THE THREE MONTHS ENDED | ||||||||
| SEPTEMBER 30, 2016 AND 2015 | ||||||||
| (UNAUDITED) | ||||||||
| Three Months Ended September 30, | ||||||||
| 2016 | 2015 | |||||||
| Revenues | $ | 849,548 | $ | 858,427 | ||||
| Cost of Goods Sold | 682,497 | 726,089 | ||||||
| Gross Profit | 167,051 | 132,338 | ||||||
| Research and Development Expenses, net | 116,992 | 150,768 | ||||||
| Selling, General and Administrative Expenses | 343,782 | 365,026 | ||||||
| Gain on Sale of Assets | (315 | ) | (1,566 | ) | ||||
| Total Operating Expenses | 460,459 | 514,228 | ||||||
| Net Loss | $ | (293,408 | ) | $ | (381,890 | ) | ||
| Loss Per Share: | ||||||||
| Basic | $ | (0.04 | ) | $ | (0.06 | ) | ||
| Diluted | $ | (0.04 | ) | $ | (0.06 | ) | ||
| Weighted average common shares outstanding: | ||||||||
| Basic | 7,539,582 | 6,389,806 | ||||||
| Diluted | 7,539,582 | 6,389,806 | ||||||
| PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES | ||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| FOR THE THREE MONTHS ENDED | ||||||||
| SEPTEMBER 30, 2016 AND 2015 | ||||||||
| (UNAUDITED) | ||||||||
| Three Months Ended September 30, | ||||||||
| 2016 | 2015 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Loss | $ | (293,408 | ) | $ | (381,890 | ) | ||
| Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities: | ||||||||
| Depreciation and Amortization | 7,621 | 5,541 | ||||||
| Gain on Sale of Assets | (315 | ) | (1,566 | ) | ||||
| Stock-based Compensation Expense | 60,901 | 100,323 | ||||||
| Non-cash Consulting Expense | 8,550 | 4,500 | ||||||
| Changes in Operating Assets and Liabilities: | ||||||||
| Accounts Receivable, net | 184,327 | 128,914 | ||||||
| Inventories | 140,979 | 54,529 | ||||||
| Prepaid Expenses | 6,297 | 7,194 | ||||||
| Accounts Payable | 60,085 | (40,809 | ) | |||||
| Customer Advances | 11,025 | 3,500 | ||||||
| Accrued Expenses | (28,274 | ) | (5,320 | ) | ||||
| Net Cash Provided From (Used In) Operating Activities | 157,788 | (125,084 | ) | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Additional Patent Costs | (340 | ) | (1,443 | ) | ||||
| Purchases of Property and Equipment | (3,500 | ) | (4,372 | ) | ||||
| Proceeds from Sale of Assets | 315 | 1,566 | ||||||
| Net Cash Used In Investing Activities | (3,525 | ) | (4,249 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Payment of Capital Lease Obligation | (1,916 | ) | – | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 152,347 | (129,333 | ) | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 50,059 | 241,051 | ||||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 202,406 | $ | 111,718 | ||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
| Cash Paid for Income Taxes | $ | – | $ | 912 | ||||